First Allied Advisory Services’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$206K Sell
3,786
-300
-7% -$16.2K 0.01% 1058
2020
Q2
$210K Sell
4,086
-435
-10% -$21.9K 0.01% 979
2020
Q1
$203K Sell
4,521
-1,590
-26% -$80.2K 0.01% 929
2019
Q4
$326K Sell
6,111
-2,637
-30% -$130K 0.01% 897
2019
Q3
$409K Sell
8,748
-15
-0.2% -$718 0.01% 754
2019
Q2
$441K Buy
8,763
+585
+7% +$28.9K 0.02% 726
2019
Q1
$419K Sell
8,178
-18
-0.2% -$896 0.01% 731
2018
Q4
$387K Sell
8,196
-306
-4% -$15.7K 0.02% 689
2018
Q3
$478K Buy
8,502
+2,124
+33% +$116K 0.02% 741
2018
Q2
$325K Sell
6,378
-63
-1% -$3.12K 0.01% 844
2018
Q1
$319K Sell
6,441
-348
-5% -$17.9K 0.01% 839
2017
Q4
$351K Buy
6,789
+57
+0.8% +$2.93K 0.01% 802
2017
Q3
$355K Hold
6,732
0.02% 742
2017
Q2
$351K Buy
6,732
+2,076
+45% +$105K 0.02% 755
2017
Q1
$234K Sell
4,656
-1,878
-29% -$93K 0.01% 914
2016
Q4
$308K Sell
6,534
-147
-2% -$6.97K 0.02% 773
2016
Q3
$333K Buy
6,681
+246
+4% +$12.5K 0.02% 703
2016
Q2
$307K Hold
6,435
0.02% 730
2016
Q1
$296K Sell
6,435
-192
-3% -$8.98K 0.02% 745
2015
Q4
$359K Sell
6,627
-192
-3% -$10.1K 0.02% 706
2015
Q3
$337K Sell
6,819
-879
-11% -$50.4K 0.02% 694
2015
Q2
$447K Buy
7,698
+2,826
+58% +$165K 0.02% 646
2015
Q1
$284K Buy
+4,872
New +$267K 0.02% 804

Other funds holding IHE

First Allied Advisory Services's IHE Position: Q3 2020 in Review

First Allied Advisory Services reduced its iShares US Pharmaceuticals ETF (IHE) stake by 7.3% in Q3 2020, selling an estimated $16.2K and leaving 3,786 shares worth $206K. The position accounts for 0.01% of the portfolio, ranked #1058.

First Allied Advisory Services first reported a position in IHE in Q1 2015 and has held it in 23 quarters since. The position peaked at $478K in Q3 2018. 94 funds tracked by Wall St. Rank hold IHE as of Q3 2020.

  • First Allied Advisory Services held 3,786 shares of iShares US Pharmaceuticals ETF worth $206K as of Q3 2020.
  • First Allied Advisory Services sold 300 iShares US Pharmaceuticals ETF shares in Q3 2020, an estimated $16.2K.
  • iShares US Pharmaceuticals ETF made up 0.01% of First Allied Advisory Services's portfolio in Q3 2020, its #1058 holding.
  • First Allied Advisory Services first reported a position in iShares US Pharmaceuticals ETF in Q1 2015 and has held it in 23 quarters since.
  • First Allied Advisory Services's iShares US Pharmaceuticals ETF position peaked at $478K in Q3 2018.
  • 94 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q3 2020.

Based on First Allied Advisory Services's 13F filing for Q3 2020, filed 13 Nov 2020.